Could that be a typo ? the rest is interesting to say the least. Needs more follow up to clarify. Many behind the obvious collaborations may/ will surface when time is appropriate and spotlight this company and what they have in the pipeline.
Trading under a dime with real scientific possibilities to improve the lives of the blind is just too, too, attractive. I think this stock is under heavy accumulation.IMVHO. FWIW. GLTA
As a private company, Advanced Cell itself is not bound by N.I.H. rules, but its clinical trial, to be conducted with the Foundation Fighting Blindness, will be supported by the Department of Defense, so the institutes’ approval of the cells is required, Dr. Lanza said.